SCHEMBL10041307

SCHEMBL10041307

CC1c2cc(c(OCCCS(=O)(=O)O)cc2OCCCS(=O)(=O)O)C(C)c2cc(c(OCCCS(=O)(=O)O)cc2OCCCS(=O)(=O)O)C(C)c2cc(c(OCCCS(=O)(=O)O)cc2OCCCS(=O)(=O)O)C(C)c2cc1c(OCCCS(=O)(=O)O)cc2OCCCS(=O)(=O)O

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC10A2 Q12908 1/20 0.33
SCN9A Q15858 1/20 0.33
PDE5A O76074 1/20 0.33
PDE1A P54750 1/20 0.33
PDE1B Q01064 1/20 0.33
PDE4D Q08499 1/20 0.33
PDE7A Q13946 1/20 0.33
PDE1C Q14123 1/20 0.33
PDE3A Q14432 1/20 0.33
APP P05067 1/20 0.31
S1PR3 Q99500 1/20 0.31
LTA4H P09960 1/20 0.30
ALDH1A1 P00352 2/20 0.30
LMNA P02545 2/20 0.30
POLB P06746 2/20 0.30
RAB9A P51151 2/20 0.30
SMN1; SMN2 Q16637 2/20 0.30
NPC1 O15118 1/20 0.30
MAPT P10636 1/20 0.30
ALOX15 P16050 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10013255 0.94 SLC10A2 (0.35) SLC10A2SCN9APDE5APDE1APDE1B
SCHEMBL12120855 0.85
SCHEMBL13852026 0.72 TSHR (0.39) PDE5APDE1APDE1BPDE4DPDE7A
SCHEMBL2022996 0.72 APP (0.35) PDE5APDE1APDE1BPDE4DPDE7A
SCHEMBL29752610 0.72 F2 (0.38) PDE5APDE1APDE1BPDE4DPDE7A
SCHEMBL10020311 0.70 TSHR (0.40) S1PR3ALDH1A1LMNAPOLBRAB9A
SCHEMBL24598731 0.69 TSHR (0.46) PDE4DALDH1A1LMNASMN1; SMN2HTT
SCHEMBL14286906 0.69 TSHR (0.62) ALDH1A1LMNARAB9ASMN1; SMN2HTT
SCHEMBL11251555 0.69 TSHR (0.36) PDE5APDE1APDE1BPDE4DPDE7A
SCHEMBL24598728 0.69 TSHR (0.46) PDE5APDE1APDE1BPDE4DPDE7A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8653297-B2 Solid acid, polymer electrolyte membrane including the same, and fuel cell using the polymer electrolyte membrane SAMSUNG SDI CO., LTD. (KR) 2014-02-18 US disclosed
US-20120045711-A1 SOLID ACID, POLYMER ELECTROLYTE MEMBRANE INCLUDING THE SAME, AND FUEL CELL USING THE POLYMER ELECTROLYTE MEMBRANE SAMSUNG SDI CO., LTD (KR) 2012-02-23 US disclosed
US-8057952-B2 Polymer electrolyte membrane, method of manufacturing the same and fuel cell including the polymer electrolyte membrane SAMSUNG SDI CO., LTD. (KR) 2011-11-15 US disclosed
US-8049032-B2 Solid acid, polymer electrolyte membrane including the same, and fuel cell using the polymer electrolyte membrane SAMSUNG SDI CO., LTD. (KR) 2011-11-01 US disclosed
US-7893119-B2 Polymer electrolyte membrane, method of preparing the same and fuel cell including the same SAMSUNG SDI CO., LTD. (KR) 2011-02-22 US disclosed
US-20070202375-A1 Polymer electrolyte membrane, method of manufacturing the same and fuel cell including the polymer electrolyte membrane SAMSUNG SDI CO., LTD. (KR) 2007-08-30 US disclosed
US-20070082248-A1 Solid acid, polymer electrolyte membrane including the same, and fuel cell using the polymer electrolyte membrane SAMSUNG SDI CO., LTD. (KR) 2007-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070082248-A1 Solid acid, polymer electrolyte membrane including the same, and fuel cell using the polymer electrolyte membrane CANX, CALU, CALD1 SLC10A2 409/4885SCN9A 343/4885PDE5A 3557/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.